UBS Upgrades Scotts Miracle Gro to Buy, Lowers Price Target to $70
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsUpgradesPrice Target
UBS analyst Peter Grom upgrades Scotts Miracle Gro (NYSE:SMG) from Neutral to Buy and lowers the price target from $78 to $70.
UBS analyst Peter Grom upgrades Scotts Miracle Gro (NYSE:SMG) from Neutral to Buy and lowers the price target from $78 to $70.